Literature DB >> 6696800

Clinical evaluation of the efficacy of oral amiodarone.

W J McKenna, D M Krikler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6696800      PMCID： PMC481492          DOI： 10.1136/hrt.51.3.241

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  8 in total

1.  [Effect of amiodarone on cardiac rhythm and electrocardiograms].

Authors:  J Facquet; M Nivet; Y Grosgogeat; P Alhomme; J Vachon
Journal:  Therapie       Date:  1970 Mar-Apr       Impact factor: 2.070

2.  Side effects of long-term amiodarone therapy.

Authors:  L Harris; W J McKenna; E Rowland; D W Holt; G C Storey; D M Krikler
Journal:  Circulation       Date:  1983-01       Impact factor: 29.690

Review 3.  Amiodarone: the experience of the past decade.

Authors:  W J McKenna; E Rowland; D M Krikler
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-03

4.  Clinical efficacy of amiodarone as an antiarrhythmic agent.

Authors:  M B Rosenbaum; P A Chiale; M S Halpern; G J Nau; J Przybylski; R J Levi; J O Lázzari; M V Elizari
Journal:  Am J Cardiol       Date:  1976-12       Impact factor: 2.778

5.  Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.

Authors:  C I Haffajee; J C Love; A T Canada; L J Lesko; G Asdourian; J S Alpert
Journal:  Circulation       Date:  1983-06       Impact factor: 29.690

6.  Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.

Authors:  K Nademanee; B N Singh; J A Hendrickson; A W Reed; S Melmed; J Hershman
Journal:  Circulation       Date:  1982-07       Impact factor: 29.690

7.  The QT interval: a predictor of the plasma and myocardial concentrations of amiodarone.

Authors:  N M Debbas; C du Cailar; R S Bexton; J G Demaille; A J Camm; P Puech
Journal:  Br Heart J       Date:  1984-03

8.  Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: relation to inducibility at electrophysiologic testing.

Authors:  D Roy; H L Waxman; M G Kienzle; A E Buxton; F E Marchlinski; M E Josephson
Journal:  Am J Cardiol       Date:  1983-11-01       Impact factor: 2.778
  8 in total
  1 in total

Review 1.  Pharmacologic treatment of hypertrophic cardiomyopathy: beta-blockade or calcium blockade or what?

Authors:  J F Goodwin
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.